Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,134 | 362 | 91.4% |
| Gift | $356.10 | 1 | 5.3% |
| Education | $219.65 | 5 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,601 | 98 | $0 (2022) |
| Allergan, Inc. | $666.63 | 49 | $0 (2022) |
| ABBVIE INC. | $540.07 | 32 | $0 (2022) |
| NxThera, Inc. | $520.84 | 8 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $315.79 | 9 | $0 (2023) |
| Janssen Biotech, Inc. | $310.20 | 23 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $196.94 | 2 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $190.31 | 9 | $0 (2021) |
| NeoTract Inc. | $175.31 | 6 | $0 (2020) |
| Myovant Sciences Inc. | $170.80 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $222.33 | 2 | Endo Pharmaceuticals Inc. ($222.33) |
| 2022 | $1,002 | 54 | ABBVIE INC. ($145.66) |
| 2021 | $1,353 | 78 | Astellas Pharma US Inc ($300.94) |
| 2020 | $837.36 | 53 | Allergan, Inc. ($220.12) |
| 2019 | $909.91 | 56 | Astellas Pharma US Inc ($300.96) |
| 2018 | $1,090 | 61 | Astellas Pharma US Inc ($414.12) |
| 2017 | $1,294 | 64 | NxThera, Inc. ($509.93) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $97.48 | General |
| Category: UROLOGY | ||||||
| 02/22/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: UROLOGY | ||||||
| 10/28/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Urology | ||||||
| 10/26/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Urology | ||||||
| 10/25/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Diagnostic Imaging | ||||||
| 10/22/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/15/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Urology | ||||||
| 10/13/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 10/13/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/05/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/03/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Oncology | ||||||
| 09/27/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/26/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/09/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/31/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.72 | General |
| 08/29/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/24/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Urology | ||||||
| 08/17/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Oncology | ||||||
| 08/10/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/08/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: UROLOGY | ||||||
| 07/22/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/18/2022 | Accord Healthcare, Inc. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Oncology | ||||||
| 07/15/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Diagnostic Imaging | ||||||
| 07/06/2022 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 784 | 941 | $527,424 | $68,012 |
| 2022 | 19 | 1,711 | 2,590 | $669,342 | $184,359 |
| 2021 | 24 | 2,135 | 3,424 | $981,769 | $283,039 |
| 2020 | 23 | 2,431 | 3,789 | $1.1M | $301,413 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 204 | 259 | $108,521 | $19,023 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 158 | 175 | $47,600 | $7,309 | 15.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 15 | $56,736 | $6,844 | 12.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 83 | 100 | $71,700 | $5,705 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 69 | $28,911 | $5,121 | 17.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 80 | $34,040 | $4,958 | 14.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 13 | 14 | $46,464 | $4,507 | 9.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 53 | 55 | $39,775 | $3,610 | 9.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 50 | $13,600 | $2,167 | 15.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 20 | $23,552 | $2,118 | 9.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 16 | 16 | $16,320 | $1,888 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 33 | 33 | $11,869 | $1,806 | 15.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 20 | 22 | $15,774 | $1,224 | 7.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 11 | 11 | $9,988 | $1,118 | 11.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 21 | 22 | $2,574 | $614.90 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 503 | 779 | $156,129 | $47,330 | 30.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 25 | 201 | $80,400 | $27,888 | 34.7% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 221 | 290 | $84,100 | $21,826 | 26.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 99 | 113 | $45,704 | $20,215 | 44.2% |
| 53854 | Destruction of prostate tissue using radiofrequency induced heated water vapor | Office | 2022 | 14 | 14 | $105,000 | $18,040 | 17.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 17 | 20 | $61,724 | $9,543 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 90 | $22,762 | $7,445 | 32.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 57 | $17,100 | $5,899 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 77 | 77 | $23,100 | $5,292 | 22.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 17 | 18 | $9,000 | $4,347 | 48.3% |
About Dr. David Heiser, MD
Dr. David Heiser, MD is a Urology healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750380861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Heiser, MD has received a total of $6,710 in payments from pharmaceutical and medical device companies, with $222.33 received in 2023. These payments were reported across 368 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($6,134).
As a Medicare-enrolled provider, Heiser has provided services to 7,061 Medicare beneficiaries, totaling 10,744 services with total Medicare billing of $836,823. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Canton, OH
- Active Since 07/20/2005
- Last Updated 12/23/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1750380861
Products in Payments
- BOTOX (Biological) $710.64
- XTANDI (Drug) $652.18
- Rezum (Device) $520.84
- MYRBETRIQ (Drug) $294.85
- XIAFLEX (Biological) $278.16
- Myrbetriq (Drug) $253.19
- LUPRON DEPOT (Drug) $239.00
- Erleada (Drug) $208.18
- Xtandi (Drug) $194.37
- UroLift (Device) $175.31
- ORGOVYX (Drug) $170.80
- GEMTESA (Drug) $169.57
- Axumin (Drug) $159.98
- JELMYTO (Drug) $131.76
- PROVENGE (Drug) $125.40
- ELIGARD (Drug) $116.50
- Nubeqa (Drug) $101.10
- ZYTIGA (Drug) $95.51
- Lupron (Drug) $91.58
- Xofigo (Drug) $89.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Canton
Carl Capelouto, M.d, M.D
Urology — Payments: $46,769
Dr. Yasin Bhanji, Md, MD
Urology — Payments: $16,581
Steven Ochs, Md, MD
Urology — Payments: $14,582
Bechara Tabet, Md, MD
Urology — Payments: $6,110
Dr. Lars Thompson, Md, MD
Urology — Payments: $5,945
Dr. Jeffrey Cerone, M.d, M.D
Urology — Payments: $5,706